Aether Bio
Company

Last deal

$49.M

Amount

Series A

Stage

15.08.2023

Date

10

all rounds

$49.1M

Total amount

General

About Company
Aether Bio develops machine learning technology to create new compounds from enzymes.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Aether

founded date

01.01.2017

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company's technology combines machine learning with high-throughput robotic laboratories to engineer enzymes and generate large datasets, allowing clients to manufacture complex and novel products at a fraction of the cost. Aether Bio's proprietary hardware enables massively parallelized experimentation, providing datasets orders of magnitude larger than the competition. The company's goal is to build a future of abundance by reverse engineering the machinery of nature to manufacture any arrangement of atoms desired, enabling the production of new products anywhere on earth.
Contacts